CIK 0001818331 · Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851966622
- Phone
- 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- 4 Open-market sale Chief Executive Officer sold 3,657 shares at an average $128.06 ($468,297)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 1,272 shares at an average $128.05 ($162,886)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 378 shares at $125.81 ($47,556)
- 4 Open-market sale Director sold 39,222 shares at an average $127.37 ($4,995,801)
- 4 Open-market sale Director sold 500,000 shares at $120.90 ($60,451,950)
- 4/A Option exercise Director acquired 12,924 shares (option exercise)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 388 shares at $105.31 ($40,860)
- 4 Open-market sale Chief Executive Officer sold 2,154 shares at $105.31 ($226,838)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 5,278 shares at $93.00 ($490,854)
- 4 Planned sale Chief Executive Officer sold 3,220 shares at $93.00 ($299,460)
- 4 Planned sale Chief Executive Officer sold 9,657 shares at an average $90.94 ($878,181)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 1,344 shares at an average $91.12 ($122,471)
- 4 Option exercise Director acquired 12,924 shares (option exercise)
- 4 Option exercise Director acquired 12,924 shares (option exercise)
- 4 Option exercise Director acquired 12,924 shares (option exercise)
- 4 Option exercise Director acquired 12,924 shares (option exercise)
- 4 Option exercise Director acquired 12,924 shares (option exercise)
- 4 Option exercise Director acquired 12,924 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 10,501 shares at $64.77 ($680,181)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 3,729 shares at $64.77 ($241,539)
Page 4 of 22 · 438 filings